TRCT
OMCL icon

Tower Research Capital (TRC)’s Omnicell OMCL Stock Holding History

Tower Research Capital (TRC)’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56K Sell
1,349
-2,102
-61% -$84.7K ﹤0.01% 2637
2026
Q1 		$115K Sell
3,451
-150
-4% -$6.28K ﹤0.01% 2073
2025
Q4 		$163K Buy
3,601
+1,454
+68% +$53.2K ﹤0.01% 1595
2025
Q3 		$65.4K Sell
2,147
-2,805
-57% -$86.2K ﹤0.01% 2316
2025
Q2 		$146K Buy
4,952
+3,932
+385% +$118K ﹤0.01% 2070
2025
Q1 		$35.7K Sell
1,020
-1,496
-59% -$59.3K ﹤0.01% 2477
2024
Q4 		$112K Sell
2,516
-1,223
-33% -$54.9K ﹤0.01% 2087
2024
Q3 		$163K Sell
3,739
-2,982
-44% -$112K ﹤0.01% 1809
2024
Q2 		$182K Buy
6,721
+5,886
+705% +$170K ﹤0.01% 2154
2024
Q1 		$24.4K Sell
835
-16,558
-95% -$502K ﹤0.01% 2818
2023
Q4 		$654K Buy
17,393
+9,778
+128% +$360K 0.01% 1164
2023
Q3 		$343K Buy
7,615
+1,829
+32% +$111K 0.01% 1098
2023
Q2 		$426K Buy
5,786
+3,533
+157% +$238K 0.01% 1078
2023
Q1 		$132K Sell
2,253
-4,604
-67% -$254K ﹤0.01% 1629
2022
Q4 		$346K Buy
6,857
+2,623
+62% +$158K 0.01% 927
2022
Q3 		$369K Buy
4,234
+2,611
+161% +$274K 0.01% 1384
2022
Q2 		$184K Sell
1,623
-2,910
-64% -$334K ﹤0.01% 1822
2022
Q1 		$587K Buy
4,533
+3,960
+691% +$571K 0.01% 1064
2021
Q4 		$103K Sell
573
-4,413
-89% -$765K ﹤0.01% 2202
2021
Q3 		$740K Buy
4,986
+2,823
+131% +$433K 0.02% 720
2021
Q2 		$327K Sell
2,163
-6,279
-74% -$874K 0.01% 1523
2021
Q1 		$1.1M Buy
8,442
+4,417
+110% +$566K 0.02% 732
2020
Q4 		$483K Sell
4,025
-24,097
-86% -$2.36M 0.01% 1016
2020
Q3 		$2.1M Buy
28,122
+21,600
+331% +$1.5M 0.02% 363
2020
Q2 		$460K Buy
+6,522
New +$446K 0.02% 1104
2019
Q4 		– Sell
-28
Closed -$2K – 4136
2019
Q3 		$2K Sell
28
-434
-94% -$31.9K ﹤0.01% 3716
2019
Q2 		$40K Buy
+462
New +$37.5K ﹤0.01% 1743
2019
Q1 		– Sell
-155
Closed -$9K – 4149
2018
Q4 		$9K Buy
155
+22
+17% +$1.49K ﹤0.01% 2559
2018
Q3 		$10K Buy
+133
New +$8.38K ﹤0.01% 2771
2018
Q2 		– Sell
-529
Closed -$23K – 3938
2018
Q1 		$23K Sell
529
-732
-58% -$33.7K ﹤0.01% 2099
2017
Q4 		$61K Buy
1,261
+96
+8% +$4.84K 0.01% 1185
2017
Q3 		$59K Buy
+1,165
New +$55.8K ﹤0.01% 1820
2016
Q3 		– Sell
-4,374
Closed -$150K – 4201
2016
Q2 		$150K Buy
4,374
+3,754
+605% +$117K 0.01% 853
2016
Q1 		$17K Sell
620
-3,830
-86% -$105K ﹤0.01% 1479
2015
Q4 		$138K Buy
+4,450
New +$131K 0.02% 246
2015
Q3 		– Sell
-299
Closed -$11K – 4554
2015
Q2 		$11K Sell
299
-1,867
-86% -$68.1K ﹤0.01% 2626
2015
Q1 		$76K Buy
+2,166
New +$71.4K 0.01% 1130
2014
Q4 		– Sell
-890
Closed -$24K – 4499
2014
Q3 		$24K Buy
+890
New +$24.4K ﹤0.01% 2161
2014
Q1 		– Sell
-898
Closed -$23K – 4787
2013
Q4 		$23K Sell
898
-3,076
-77% -$73.5K ﹤0.01% 2172
2013
Q3 		$94K Buy
3,974
+3,732
+1,542% +$83.2K 0.01% 1357
2013
Q2 		$5K Buy
+242
New +$4.47K ﹤0.01% 2949

Other funds holding OMCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Tower Research Capital (TRC)'s OMCL Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Omnicell (OMCL) stake by 61% in Q2 2026, selling an estimated $84.7K and leaving 1,349 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #2637.

Tower Research Capital (TRC) first reported a position in OMCL in Q2 2013 and has held it in 41 quarters since. The position peaked at $2.1M in Q3 2020. 306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Tower Research Capital (TRC) held 1,349 shares of Omnicell worth $56K as of Q2 2026.
  • Tower Research Capital (TRC) sold 2,102 Omnicell shares in Q2 2026, an estimated $84.7K.
  • Omnicell made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2637 holding.
  • Tower Research Capital (TRC) first reported a position in Omnicell in Q2 2013 and has held it in 41 quarters since.
  • Tower Research Capital (TRC)'s Omnicell position peaked at $2.1M in Q3 2020.
  • 306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.